logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESMO 2018 – Patients with HPV-positive oropharynx cancer should receive chemoradiation and not cetuximab plus radiotherapy

An independent trial shows that new treatments in HPV+ throat cancer are not always better than old ones, but more studies are needed to improve patient selection based on molecular profiles